Commercial Litigation and Arbitration

October 4, 2008

From In re Zyprexa Prods. Liab. Litig., 2008 U.S. Dist. LEXIS 71037 (E.D.N.Y. Sept. 5, 2008): Dr. Rosenthal also estimated unjust enrichment damages--with lower-and upper-bound estimates of $ 3.7 billion and $ 7.1 billion--over the class period. See Rosenthal Decl. 44-47. Her calculations are not discussed further here since the ...
From In re Zyprexa Prods. Liab. Litig., 2008 U.S. Dist. LEXIS 71037 (E.D.N.Y. Sept. 5, 2008): Dr. Rosenthal also estimated unjust enrichment damages–with lower-and upper-bound estimates of $ 3.7 billion and $ 7.1 billion–over the class period. See Rosenthal Decl.…

Recent Articles

Archives